These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29056013)

  • 41. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
    Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease.
    Tan YW; Wang JM; Zhou XB
    World J Hepatol; 2023 Feb; 15(2):237-254. PubMed ID: 36926239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.
    Paul J; Venugopal RV; Peter L; Shetty KNK; Shetti MP
    Arq Gastroenterol; 2018; 55(1):7-13. PubMed ID: 29561981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].
    Shi JP; Fan JG; Wu R; Gao XQ; Zhang L; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):519-23. PubMed ID: 18647531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without.
    Chu CM; Lin DY; Liaw YF
    Dig Dis Sci; 2013 Jan; 58(1):275-81. PubMed ID: 22903182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters.
    Rastogi A; Sakhuja P; Kumar A; Hissar S; Jain A; Gondal R; Sarin SK
    Indian J Pathol Microbiol; 2011; 54(3):454-9. PubMed ID: 21934202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Protective effects of rhein on hepatic progression in HBV-transgenic mice with nonalcoholic steatohepatitis induced by a high-fat diet].
    Bian DX; Liu J; Lu L; Liu H; Guo JC; Yang WJ; Liu YL; Luo Y; Zhuang ZJ; Chen JY; Shi JP; Xun YH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):328-31. PubMed ID: 24645314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors.
    Minakari M; Molaei M; Shalmani HM; Mohammad Alizadeh AH; Jazi AH; Naderi N; Shavakhi A; Mashayekhi R; Zali MR
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):512-6. PubMed ID: 19190500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [ANTHROPOMETRIC CHARACTERISTICS AND PARAMETERS OF LIPID-CARBOHYDRATE METABOLISM IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND HYPERTENSION DEPENDING ON THE DEGREE OF HEPATIC STEATOSIS].
    Babak О; Bashkirova А
    Georgian Med News; 2018 Nov; (284):59-65. PubMed ID: 30618391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-21 Is Associated with Early Antiviral Response in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease.
    Liu X; Shen Z; Zhang H; Liang J; Lin H
    J Interferon Cytokine Res; 2016 Jun; 36(6):367-73. PubMed ID: 26840345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.
    Yu MW; Lin CL; Liu CJ; Huang YW; Hu JT; Wu WJ; Wu CF
    J Formos Med Assoc; 2022 Aug; 121(8):1478-1487. PubMed ID: 34764005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Criteria Correlated with the Incidence of Patients with Non-alcoholic Fatty Liver Disease.
    Chien-Min K; Cheng-Chuan L
    Ann Clin Lab Sci; 2017 Mar; 47(2):191-200. PubMed ID: 28442522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.
    Papatheodoridis GV; Chrysanthos N; Cholongitas E; Pavlou E; Apergis G; Tiniakos DG; Andrioti E; Theodossiades G; Archimandritis AJ
    J Hepatol; 2009 Nov; 51(5):931-8. PubMed ID: 19726097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steatosis and serum lipid patterns in patients with chronic viral hepatitis: differences related to viral etiology.
    Vere CC; Neagoe D; Streba CT; Prejbeanu I; Ianoşi G; Comănescu V; Pirici D
    Rom J Morphol Embryol; 2010; 51(3):509-14. PubMed ID: 20809028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects.
    Ding WJ; Wang MM; Wang GS; Shen F; Qin JJ; Fan JG
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1753-8. PubMed ID: 25974331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.